Deadline: April 23, 2012
Website: http://tripll.org/resources/pilot-study-funding/2012-pilot-study-program/
Contact: (212) 746-1237, Allison Nickerson, als2053@med.cornell.edu
The Program emphasizes investigator development and mentorship, offering grantees unique opportunities to build research across disciplines, institutions and settings.
Topics of research can include:
Deadline: April 24, 2012
Website: www.themmrf.org/research-programs/for-academic-researchers/grant-opportunities.html
Contact: Mariadora Saladino saladinom@themmrf.org
The Multiple Myeloma Research Foundation (MMRF) seeks proposals for the MMRF 2012 Research Fellow Award Program, an initiative supporting researchers with less than five years' experience (post highest degree obtained, doctorate or equivalent) working under the supervision of a research mentor in the multiple myeloma field. The goal of this initiative is to help support young investigators studying in the field of multiple myeloma while advancing the understanding of myeloma disease biology, treatment and drug resistance. Proposals may request up to $75,000 for one (1) year and will be reviewed by a committee, comprised of myeloma and other oncology or technology experts, appointed by the MMRF.
Deadline: May 2, 2012
Website: http://www.bsf.org.il/bsfpublic/DefaultPage1.aspx?PageId=25&innerTextID=25
Contact:
BSF is announcing the availability of funds for short scientific trips by young American or Israeli scientists to the other country. In 2012 the program will have two calls and each will support 10 trips. Grants will be $4,000 each. The program is open to PhD students and post-doc fellows doing research that requires facilities or expertise that are not available in their home countries.
Deadline: May 4, 2012
Website: www.alzdiscovery.org
Contact: Joan L. Headley director@post-polio.org
The Research Fund supports the work of researchers investigating the late effects of poliomyelitis and/or neuromuscular respiratory disease through one of two grants: The Thomas Wallace Rogers Memorial Respiratory Research Grant to study the cause(s) and treatment of neuromuscular respiratory insufficiency and the effects of long-term home mechanical ventilation. The Post-Poliomyelitis Research Grant to study the cause(s), treatment and management of problems of the late effects of polio. The cattegories are Clinical Research, Basic Research, Lung and Respiratory Function and Disease, and Neuromuscular. Applicants must be affiliated with an institution or organization. Citizens of all countries may apply. Applications must be in English. One grant for a maximum of $25,000 is available.
Deadline: May 4, 2012
Website: www.aamc.org/initiatives/awards/nickens-faculty/101278/nickens_faculty_overview.html
Contact:
The award recognizes an outstanding junior faculty member who has demonstrated leadership in the United States in addressing inequities in medical education and health care; demonstrated efforts in addressing educational, societal, and health care needs of minorities; and is committed to a career in academic medicine. The recipient receives a $15,000 grant to support his or her academic and professional activities. Funding for the fellowship begins in November of the year the fellowship is awarded. The recipient will be required to submit a final narrative and financial reports.
Deadline: May 4, 2012
Website: www.onebreath.org/page.aspx?pid=397
Contact: (847) 498-1400, onebreath@chestnet.org
This award supports a project that contributes to the understanding of the pathophysiology or treatment of Pulmonary Arterial Hypertension (PAH) that is based on clinical/translational research and not basic or bench level research. ACCP members who have completed at least 2 years of pulmonary or critical care fellowship and be within and are within 7 years of completing training will be considered for this award.
$50,000 for 1-year
Deadline: May 4, 2012
Website: www.onebreath.org/page.aspx?pid=397
Contact: (847) 498-1400, onebreath@chestnet.org
This award supports a project in lung cancer research that leads to improved treatment of lung cancer and is based on clinical/translational research and not basic or bench level research. ACCP members who have completed at least 2 years of pulmonary or critical care fellowship or a thoracic surgery residency and be within and are within 7 years of completing training will be considered for this award.
The OneBreath Clinical Research Award in Lung Cancer - $100,000 over 2 years.
Deadline: May 4, 2012
Website: www.onebreath.org/page.aspx?pid=397
Contact: 847) 498-1400, onebreath@chestnet.org
The Distinguished Scholar in Critical Care supports clinical educational projects to improve patient care and is intended for the investigation of issues that are not easily supported through traditional funding. The award will support an American College of Chest Physicians Fellow (FCCP) who proposes a critical care-related project/service that does one or more of the following:
$150,000 awarded over 3 years
Deadline: May 10, 2012
Website: http://www07.grants.gov/search/search.do?&mode=VIEW&oppId=147273
Contact: help@cdmrp.org
The PRMRP Investigator-Initiated Research Award (IIRA) is intended to support studies that will make an important contribution toward research and/or patient care for a disease or condition related to at least one of the congressionally directed FY12 PRMRP topic areas. Research projects may focus on any phase of research from basic laboratory research through translational research, including preclinical studies in animal models and human subjects, as well as correlative studies associated with an existing clinical trial. The rationale for a research idea may be derived from a laboratory discovery, population-based studies, or a clinician's first-hand knowledge of patients and anecdotal data. Applications must include relevant data that support the rationale for the proposed study. These data may be unpublished and/or from the published literature.
Deadline: May 15, 2012
Website: www.jmfund.org/grant.php
Contact: (617) 556-4120, nstockford@jmfund.org
The John Merck Fund has had a longstanding interest in people with intellectual and developmental disorders since its inception in 1970. Starting in 2012, JMF will launch the Developmental Disabilities Translational Research Program, which will support researchers in developing treatments and improving outcomes for individuals with developmental disabilities, particularly Down syndrome and Fragile X syndrome (and FX associated disorders). The awards will be made to the most highly innovative translational research projects that have the greatest potential of investigating rational and effective treatments and interventions for the particular condition being addressed. The program will emphasize interdisciplinary collaborative grant applications focused primarily on FXS and DS, but the program will support studies focused on other developmental disabilities under special circumstances. The Fund is particularly interested in translational research that is designed to improve the lives of people with developmental disabilities and their families. Investigators from a range of disciplines are encouraged to apply.
Deadline: June 8, 2012
Website: www.childrensheartfoundation.org
Contact: 847-634-6474, William Foley, bfoley@childrensheartfoundation.org
CHF is a leading charitable organization funding the most promising congenital heart defect (CHD) research. The Foundation supports new research and accelerates the pace of critical research waiting for funding in the following areas: Molecular genetics / biochemistry, Devices/Procedural Research (catheterization & surgical) and Long-term care of CHD children as they become adults.
No single project may receive more than $100,000 in CHF funds during any calendar year.
Deadline: Ongoing
Website: www.ellisonfoundation.org/index.jsp
Contact: grants@solvingkidscancer.org
The development of new therapies for pediatric cancers with the poorest outcomes is essential to improving survivorship. Solving Kids' Cancer focuses on expanding the menu of therapeutic options to positively impact children in treatment today as well as those diagnosed in the future through clinical studies of novel agents.
In the next two years, more pediatric cancer genomes will be decoded with additional pathways and targets identified. Numerous candidate agents and delivery mechanisms that potentially target these biological discoveries will need to be studied in children to confirm their biologic relevance. The Therapeutic Development Initiative(TDI) is Solving Kids' Cancer's strategic program to support the investigation of novel treatments through clinical studies to answer important research questions as quickly, effectively, and economically as possible.
The TDI utilizes a pre-proposal format called a Clinical Idea of Intent for all submissions that is used to evaluate your proposal's fit with the stated aims and review criteria of the TDI. All submitted Clinical Ideas of Intent will be reviewed through a triage process and those proposals meeting the aims of the program will be requested to submit further proposal details. Proposals can be submitted open-ended throughout the year, keeping in-mind that proposals received earlier have a greater chance of support based on the programming budget.
Deadline: Ongoing
Website: www.autismspeaks.org/science/research/grants/open_grants_how_to_apply.php
Contact: (609) 228-7313, Joan New jnew@autismspeaks.org
Autism Speaks places a high priority on innovation and has designed its new Trailblazer Award to respond quickly to fund highly novel transformative projects. The Trailblazer Award mechanism will support highly novel "out of the box" autism-relevant research that opens new avenues to understanding the causes, diagnosis, subtyping, prevention, treatments, and cure of autism spectrum disorders. The Trailblazer Award mechanism is designed to fund small investigator-initiated high risk/high impact projects that are potentially transformative, paradigm shifting, and/or will overcome significant roadblocks in autism research within a 12 month period. The cattegories are Developmental Disabilities, Environmental Health, Genetics, Basic Research, Cellular/Molecular Biology, Clinical Research and Communication Disorders.
Investigators holding full-time tenured or tenure-track faculty appointments or equivalent full-time non-tenure track appointments at accredited academic, medical or research institutions are eligible to apply. Eligibility must be demonstrated at the time of registration. Applicants who do not meet the eligibility criteria above (e.g., postdoctoral fellows, medical residents, clinical fellows, part-time faculty members, etc.) are eligible to apply only if the Letter of Intent section includes clear documentation from the applicant's institution stating that appointment to a full-time, faculty position will be in effect by the start date of the grant.
Submission of a Letter of Intent page in the online grant system is required. If your LOI is approved, you will be invited to complete the application. The relevance of the proposed research to the Autism Speaks 2010 targeted research priority areas must be explicitly stated. Trailblazer awards are limited to a period of 12 months and an amount up to $100,000.
The CTSC is funded through grant UL1 RR024996 from the National Center for Research Resources, National Institutes of Health.
© Clinical and Translational Science Center
